Compare Natera Inc. Common Stock (NTRA) vs Pacific Gas & Electric Co. Common Stock (PCG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Natera Inc. Common Stock vs Pacific Gas & Electric Co. Common Stock — how do they compare? Natera Inc. Common Stock trades at $394.16 (market cap $57.03B), while Pacific Gas & Electric Co. Common Stock trades at $13.24 (market cap $40.02B). The key difference: Natera Inc. Common Stock is the larger of the two by market cap, and Pacific Gas & Electric Co. Common Stock pays a 1.5% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and Pacific Gas & Electric Co. Common Stock for 6 Days on average.
| NTRA | PCG | |
|---|---|---|
Market Cap | $57.03B | $40.02B |
Volume | 1,131,157 | 38,222,102 |
Sector | Health | Utilities |
52-Week High | $425.64 | $19.11 |
52-Week Low | $179.42 | $11.95 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $56.18B | $105.33B |
Dividend Yield | — | 1.5% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
PCG trades at $13.33, up 1.29% with a bullish technical signal despite mixed momentum indicators. The stock shows strong fundamentals with a P/E of 9.59 and net income margin of 12.25%, supported by recent earnings beats. Recent news highlights PG&E's proactive wildfire safety measures and strategic initiatives, including a 10-year undergrounding plan to mitigate risks. Analyst consensus remains positive with a $18.22 price target, though technical indicators show some overbought conditions.
PCG presents a value opportunity with attractive valuation metrics and improving profitability, but faces significant wildfire-related risks and regulatory uncertainty. The stock's upside potential depends on successful execution of safety initiatives and favorable regulatory outcomes, making it suitable for risk-tolerant investors seeking utility exposure with growth potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →About Pacific Gas & Electric Co. Common Stock
PG&E Corporation is the parent company of Pacific Gas and Electric Company, a utility serving Northern and Central California. Its main business is the sale and delivery of electricity and natural gas.
Read more on PCG →
